April 8, 2022— New research demonstrates the essential role that the 340B drug pricing program played for safety-net hospitals in a year marked by enormous financial pressures that were both naturally occurring and manmade. An annual 340B Health survey of more than 500 hospitals participating in 340B found that all reported using savings they received through drug discounts … [Read more...]
Faces of 340B: A Prescription for Improved Quality of Life
July 20, 2020— A decade-and-a-half ago, Chicago patient Hanan Tadros was feeling overwhelmed. She was struggling to manage her multiple chronic health conditions and juggle her more than 10 prescription medications for diabetes, depression, and more. That’s when a hospital participating in the 340B drug pricing program intervened to help change her life for the … [Read more...]
340B Means Better Diabetes Care
May 8, 2020— The threat of chronic diseases such as diabetes has not taken a break during the nation’s response to the COVID-19 pandemic. More than one in 10 Americans are living with diabetes, with typically underserved populations hit hard not only by the disease but also by the life-threatening complications that can come with it. The pandemic only serves to make the … [Read more...]
340B Data Show How Savings Help Patients with Low Incomes and Protect Access in Rural Areas
April 2, 2020— Results from 340B Health’s annual survey of hospitals confirms the 340B drug pricing program is working the way Congress intended. Surveyed 340B hospitals report using their savings from prescription drug discounts to improve access to care and health outcomes for patients with low incomes and those living in rural communities. Hospital savings go to maintain or … [Read more...]